RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6
Rhea-AI Summary
RxSight (NASDAQ: RXST) will report first-quarter 2026 financial results on May 6, 2026 after market close.
Management will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET with dial-in numbers and a listen-only webcast on the company investor relations site; an archived recording will be posted after the call.
Positive
- None.
Negative
- None.
News Market Reaction – RXST
In the Apr 23 session, RXST declined 2.70%, reflecting a moderate negative market reaction. Our momentum scanner triggered 6 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 11 | Earnings date notice | Neutral | -2.9% | Announced Q4 and full-year 2025 results date and conference call details. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Prior earnings date scheduling news was followed by a modest negative move, suggesting such notices have not historically driven sustained strength.
This announcement schedules RxSight’s Q1 2026 results call, similar to the prior earnings date notice on Feb 11, 2026, which preceded a -2.86% move. Recent news has included Q4 2025 results and 2026 guidance with a -10.1% reaction, a preliminary 2025 update with CFO appointment that saw a 14.14% move, and a product milestone update that coincided with a -7.01% reaction. Against this mixed backdrop, the latest earnings date notice fits an ongoing cadence of financial communications.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ALISO VIEJO, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., today announced that it will report financial results for the first quarter after the market close on Wednesday, May 6, 2026. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
To participate in the conference call, please dial (800) 715-9871 or (646) 307-1963, and enter the conference code: 2630350. The call will also be broadcast live in listen-only mode via a link on the company’s investor relations website at https://investors.rxsight.com/. An archived recording of the call will be available through the same link shortly after its completion.
About RxSight, Inc.
RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®/LAL+®, collectively the “LAL”), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.
Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com
